docdesc stringlengths 2 165 | dxcode stringlengths 3 8 | shortdesc stringlengths 5 155 | longdesc stringlengths 5 184 |
|---|---|---|---|
COVID 19 Pneumonia | J12.82 | Pneumonia due to coronavirus disease 2019 | Pneumonia due to coronavirus disease 2019 |
COVID 19 - SARS | U07.1 | COVID-19 | COVID-19 |
Covid 19 her influenza | U07.1 | COVID-19 | COVID-19 |
covid 19 infection (upper respiratory infection | U07.1 | COVID-19 | COVID-19 |
COVID 19 no pneumonia | U07.1 | COVID-19 | COVID-19 |
Covid 19 pneumonia, ischemic | U07.1 | COVID-19 | COVID-19 |
COVID 19 pneumonia, Severe | J12.89 | Other viral pneumonia | Other viral pneumonia |
Covid 19 symptoms here for antibody infusion | U07.1 | COVID-19 | COVID-19 |
Covid 19 testing and chest | U07.1 | COVID-19 | COVID-19 |
COVID 19 vaccination | U07.1 | COVID-19 | COVID-19 |
Covid 19, diverticulitis | U07.1 | COVID-19 | COVID-19 |
Covid 19, laryngitis | U07.1 | COVID-19 | COVID-19 |
Covid 19, pneumonia | U07.1 | COVID-19 | COVID-19 |
COVID as well as from the fracture | U07.1 | COVID-19 | COVID-19 |
COVID complications | U07.1 | COVID-19 | COVID-19 |
Covid infection Leukocytosis | U07.1 | COVID-19 | COVID-19 |
COVID infection she has been having diarrhea | U07.1 | COVID-19 | COVID-19 |
COVID infection with bronchitis | U07.1 | COVID-19 | COVID-19 |
COVID infection with pneumonia | U07.1 | COVID-19 | COVID-19 |
COVID infection, he was started on steroids | U07.1 | COVID-19 | COVID-19 |
COVID Pna sepsis | U07.1 | COVID-19 | COVID-19 |
COVID PNA W-ACUTE ANEMIA | U07.1 | COVID-19 | COVID-19 |
COVID PNA wit esp failure | U07.1 | COVID-19 | COVID-19 |
covid pna, bronchitis | U07.1 | COVID-19 | COVID-19 |
Covid PNA- ON IV steroids | U07.1 | COVID-19 | COVID-19 |
COVID pneumonia encephalopathy | U07.1 | COVID-19 | COVID-19 |
COVID pneumonia with hypoxemia | J12.82 | Pneumonia due to coronavirus disease 2019 | Pneumonia due to coronavirus disease 2019 |
COVID pneumonia with hypoxia | U07.1 | COVID-19 | COVID-19 |
COVID pneumonia, Acidosis | J12.89 | Other viral pneumonia | Other viral pneumonia |
COVID pneumonia, Acidosis | U07.1 | COVID-19 | COVID-19 |
COVID pneumonia, currently on symptomatic | J12.89 | Other viral pneumonia | Other viral pneumonia |
COVID pneumonia, dyspnea | U07.1 | COVID-19 | COVID-19 |
COVID pneumonia: persistent | J12.89 | Other viral pneumonia | Other viral pneumonia |
COVID pneumonia: persistent | U07.1 | COVID-19 | COVID-19 |
COVID PNUEMONIA HYPOXIA | U07.1 | COVID-19 | COVID-19 |
COVID POSITIVE PNEUMONIA | U07.1 | COVID-19 | COVID-19 |
COVID related complications | U07.1 | COVID-19 | COVID-19 |
Covid related pneumonia and right-sided pulmonary | J12.89 | Other viral pneumonia | Other viral pneumonia |
COVID screening test | U07.1 | COVID-19 | COVID-19 |
covid strep | U07.1 | COVID-19 | COVID-19 |
COVID symptoms: chills | U07.1 | COVID-19 | COVID-19 |
COVID test report to come back | U07.1 | COVID-19 | COVID-19 |
COVID test results came back | U07.1 | COVID-19 | COVID-19 |
COVID test results come back | U07.1 | COVID-19 | COVID-19 |
covid treatment, ischemic eval once he has | U07.1 | COVID-19 | COVID-19 |
COVID ward until his heart | U07.1 | COVID-19 | COVID-19 |
COVID, +Flu A | U07.1 | COVID-19 | COVID-19 |
COVID, FEVER | U07.1 | COVID-19 | COVID-19 |
COVID, will treat for otitis | U07.1 | COVID-19 | COVID-19 |
COVID-19 pneumonia | U07.1 | COVID-19 | COVID-19 |
COVID-19 infection 2 weeks back | U07.1 | COVID-19 | COVID-19 |
COVID-19 infection can be contributed to the hypoglycemia | U07.1 | COVID-19 | COVID-19 |
COVID-19 infection in late | U07.1 | COVID-19 | COVID-19 |
COVID-19 infection in these nine days when the patient was experiencing respiratory symptoms | U07.1 | COVID-19 | COVID-19 |
COVID-19 infection pneumonia | U07.1 | COVID-19 | COVID-19 |
COVID-19 infection standpoint the patient is stable | U07.1 | COVID-19 | COVID-19 |
COVID-19 infection with associated pneumonia | U07.1 | COVID-19 | COVID-19 |
COVID-19 infection with gastroenteritis | U07.1 | COVID-19 | COVID-19 |
COVID-19 infection, continue symptomatic treatment. | U07.1 | COVID-19 | COVID-19 |
Covid-19 Infection, Dialysis | U07.1 | COVID-19 | COVID-19 |
COVID-19 infection, SARS | U07.1 | COVID-19 | COVID-19 |
COVID-19 infection: on steroids | U07.1 | COVID-19 | COVID-19 |
COVID-19 long-haulers syndrome | U07.1 | COVID-19 | COVID-19 |
COVID-19 pneumonia infection | J12.89 | Other viral pneumonia | Other viral pneumonia |
COVID-19 pneumonia infection | U07.1 | COVID-19 | COVID-19 |
COVID-19 pneumonia with fever | J12.89 | Other viral pneumonia | Other viral pneumonia |
COVID-19 pneumonia with fever | U07.1 | COVID-19 | COVID-19 |
COVID-19 pneumonia, clinically has remained unchanged with his respiratory | U07.1 | COVID-19 | COVID-19 |
COVID-19 pneumonia, currently on hemodialysis | U07.1 | COVID-19 | COVID-19 |
COVID-19 test as well as rapid strep | U07.1 | COVID-19 | COVID-19 |
COVID-19 vaccination | U07.1 | COVID-19 | COVID-19 |
COVID19 INFECTION | U07.1 | COVID-19 | COVID-19 |
COVID19, PNEUMONIA | U07.1 | COVID-19 | COVID-19 |
cp as a muscle | R07.9 | Chest pain, unspecified | Chest pain, unspecified |
cp at the moment has moderate | R07.9 | Chest pain, unspecified | Chest pain, unspecified |
CP due to uncontrolled | R07.9 | Chest pain, unspecified | Chest pain, unspecified |
cp w/tachycardia | R07.9 | Chest pain, unspecified | Chest pain, unspecified |
CP, anxiety | R07.9 | Chest pain, unspecified | Chest pain, unspecified |
cp, bleeding. | R07.9 | Chest pain, unspecified | Chest pain, unspecified |
CP, cardiac | R07.9 | Chest pain, unspecified | Chest pain, unspecified |
cp, rrr lungs | R07.9 | Chest pain, unspecified | Chest pain, unspecified |
cramp, intermittent | R25.2 | Cramp and spasm | Cramp and spasm |
cramps in her abdomen | R25.2 | Cramp and spasm | Cramp and spasm |
craniopharyngioma | D44.4 | Neoplasm of uncertain behavior of craniopharyngeal duct | Neoplasm of uncertain behavior of craniopharyngeal duct |
Creutzfeldt-Jakob disease | A81.00 | Creutzfeldt-Jakob disease, unspecified | Creutzfeldt-Jakob disease, unspecified |
Critical Illness myopathy | G72.81 | Critical illness myopathy | Critical illness myopathy |
crohns exacerbation | K50.90 | Crohn's disease, unspecified, without complications | Crohn's disease, unspecified, without complications |
Crohns of colon | K50.90 | Crohn's disease, unspecified, without complications | Crohn's disease, unspecified, without complications |
crystalline arthropathy | M12.9 | Arthropathy, unspecified | Arthropathy, unspecified |
culture positive for Klebsiella | R89.9 | Unsp abnormal finding in specimens from oth org/tiss | Unspecified abnormal finding in specimens from other organs, systems and tissues |
culture positive for Pseudomonas | R89.9 | Unsp abnormal finding in specimens from oth org/tiss | Unspecified abnormal finding in specimens from other organs, systems and tissues |
curvature of the spine | A18.01 | Tuberculosis of spine | Tuberculosis of spine |
Cutaneous abscess of the left foot | L02.612 | Cutaneous abscess of left foot | Cutaneous abscess of left foot |
CVA - MRI watershed ischemic | I63.9 | Cerebral infarction, unspecified | Cerebral infarction, unspecified |
CVA affecting L side w/dysphagia, malignant | I69.391 | Dysphagia following cerebral infarction | Dysphagia following cerebral infarction |
CVA right-sided hemiparesis | I69.351 | Hemiplga following cerebral infrc aff right dominant side | Hemiplegia and hemiparesis following cerebral infarction affecting right dominant side |
CVA stroke | Z86.73 | Prsnl hx of TIA (TIA), and cereb infrc w/o resid deficits | Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits |
CVA with left-sided deficit | I69.354 | Hemiplga following cerebral infrc affecting left nondom side | Hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side |
CVA with residual dysarthria | I69.322 | Dysarthria following cerebral infarction | Dysarthria following cerebral infarction |
CVA with residual dysarthria, diabetes, hypertension | Z86.73 | Prsnl hx of TIA (TIA), and cereb infrc w/o resid deficits | Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits |
Subsets and Splits
Stratified Sample of 3500
Provides a stratified random sample of approximately 3500 rows, ensuring representation from all dxcode classes, which is useful for balanced data analysis and model training.
Random Validation & Test Samples
Randomly selects 750 samples from both validation and test datasets, labeling them accordingly, which provides basic data exploration but limited analytical value.
Random Sampled Dataset Split
Randomly selects a subset of records from train, validation, and test datasets, which provides basic sampling but limited analytical value.